Spotlight on Science talk on 22 January: Tuberculosis - new solutions for an old enemy

Tuberculosis, an ancient infectious disease, still causes 1.5 million deaths every year.

The BCG vaccine does not protect adults and the alarming rise of TB drug resistance is making treatment increasingly difficult. New solutions are desperately needed.


Research revealing ‘persistent bacteria’ could be key to future tuberculosis trials

Research carried out by St George’s, University of London into tuberculosis treatments has clearly shown the ‘persistent bacteria’ that make treating the disease so difficult for the first time, using a new combination therapy.

1 June 2018

MTB Cropped

St George’s to provide TB expertise to a Bill & Melinda Gates Foundation funded project

St George’s, University of London, will be directly collaborating in a far-reaching project with longstanding commercial partner QuantuMDx to further develop and test its diagnostic technologies for tuberculosis, which causes nearly three deaths every minute.

2 December 2016